![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, June 15, 2022 3:02:03 PM
6/14/22, 06:05 PM
$RGBP
The present Bear Market is to our advantage when you look at the BIG PICTURE!! Why?
# 1 down market means share price suppression which translates into opportunity for accumulating a greater number of shares at a lower pps that have a high market capacity
# 2 lower share price translates into greater attraction for a Buy Out offer, i.e. the buyer gets more bang for their buck in particular if the company has Disruptive Biotechnology Patents
# 3 A Merger/Acquisition is a shoe in for our NR2F6 where the Buyer doesn't have to do anything but fund the IND which is already in place at OP in San Francisco which is what all BPs prefer, i.e. out sourcing clinical trials to conserve in house expense and man power utilization. OP has a primary role in funding the IND however it's easier for the acquiring BP to supplement any funding they have and let them do the heavy lifting. This is a perfect set up for RGBP to move ahead into clinical trials in a Bear Market
OPINION ONLY
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM